Navigation Links
Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
Date:12/3/2007

lity of this novel compound as a new therapeutic option for patients affected by hypertension and related disorders such as diabetic nephropathy," stated Rene Belder, M.D., Pharmacopeia's Vice President of Clinical and Regulatory Affairs. "We look forward to the completion of our ongoing Phase 2a study in the first half of 2008 and hope to see the first clear demonstration of the compound's potential efficacy in hypertensive patients."

PS433540 is a dual-acting angiotensin (AII) and endothelin (ET1) receptor antagonist that is being developed as a potential treatment for hypertension and diabetic nephropathy. PS433540, the first and only DARA compound in development, possesses two clinically validated mechanisms of action in a single compound. There is considerable preclinical and initial clinical data suggesting that compared to either agent alone, simultaneously blocking the actions of both AII and ET1 may provide significantly improved treatment options for several cardiovascular diseases.

ABOUT PHARMACOPEIA

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including seven clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic agreements with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Organon, Schering-Plough, and Wyeth Pharmaceuticals. For more information please visit the company's website at h
'/>"/>

SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
3. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
4. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
5. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
6. Pharmacopeia Announces Third Quarter 2007 Financial Results
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/3/2015)... 2015  Obsidian HDS, the developer of PharmaShine ( ... the management of data on pharmaceutical and device industry ... includes the 2014 Open Payments General and Research data ... 30. The data disclosed on Open Payments for 2014 ... providers totaling $6.49 billion and is the largest public ...
(Date:7/2/2015)... Pharma Major Lupin Limited ... en ZAO "Biocom" en Rusia bajo ciertas condiciones ... Lupin en el mercado farmacéutico de Rusia que ... como uno de los 10 principales mercados farmacéuticos ... de una década, el mercado farmacéutico ruso registró ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Latin America With Medical Education 2New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Newport Audiology Centers announced that it is relocating ... The new Nashville Operations Center will allow the company ... expand operations across their consumer, business-to-business and workers, compensation ... the opportunities Nashville will bring," said David Gligor, Chief ...
... 25, 2011 The Wound and Hyperbaric ... by the Undersea and Hyperbaric Medical Society (UHMS), the ... that few hospitals and facilities have earned, and identifies ... The super oxygenation offered by hyperbaric treatments can ...
Cached Medicine Technology:Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 2Good Samaritan Hospital's Wound and Hyperbaric Institute Receives Accreditation from Undersea and Hyperbaric Medical Society, Recognizing Advanced Care 3
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... in the United States, named Mariah N. Manzanares, MD as the new Medical Director ... the new facility medical director of our Frisco facility,” said Dr. James M. Muzzarelli, ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium frozen ... companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... structure retrofit project at the University of Minnesota, they knew it would save ... would also be an award-winning choice: the total energy savings after installation was ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of ... skin cancer is on the rise. July is UV Safety Month, and physicians at ... the importance of getting skin checks. Experts say most skin cancers can be found ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... BETHESDA, Md., Jan. 12 Hanger Orthopedic Group, ... joined the organization as Executive Vice President and ... Hanger President and Chief Executive Officer Thomas F. ... identification, development, and execution of new opportunities for ...
... Neale, MC,s event with Rock & Roll Hall of ... nation,s biggest problem: the health of our peopleWASHINGTON, Jan. ... Ball announced today the complete line up of speakers ... History Museum, home of the Hope Diamond. Prominent ...
... Jan. 12 Rite Aid Corporation (Rite Aid) and ... to pay $5 million in civil penalties to settle ... the Department of Justice announced today. In addition to ... its subsidiaries agreed to a compliance plan with the ...
... report genetic match; Ohio distributor recalls two King Nut brands; ... 12 (HealthDay News) -- Lab tests on a tainted tub ... of salmonella that has sickened almost 400 people across the ... report, issued on the Minnesota Department of Health Web site, ...
... from neuropathic pain , The pain that is ... the trauma of amputation, entrapment, and compression, is known ... treatments show limited or no effectiveness. Nerve injury underlying ... immune cells are thought to be contributors to the ...
... ROCHELLE, N.Y., Jan. 12 The ... networking website, Facebook , would be well advised ... Such a policy perpetuates the notion that breastfeeding is ... a misguided and antiquated concept that has no place ...
Cached Medicine News:Health News:Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 2Health News:Health for All Inaugural Ball Brings Renowned Speakers and Entertainment to Election's Key Issue 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:Minn. Confirms Tainted Peanut Butter Link to Salmonella Outbreak 2Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Facebook Flack Regarding Breastfeeding Mothers 2
Solid 14 mm blades. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: